Lit-Control pH Balance
Commercial- Indications
- Kidney stones
Company intelligence / Profile preview
Devicare develops and commercializes innovative digital therapeutics, medical devices, and nutritional therapies focused on the treatment and prevention of kidney stones. Their lead product line Lit-Control® includes patented dietary supplements to manage urinary pH and prevent calcium oxalate stone formation. The company combines remote patient monitoring technologies with nutritional interventions to provide personalized medicine solutions in urology. Products are available across Europe, the US, and other territories.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Devicare.